IFRX InflaRx NV Net earnings per share growth forecast for next year
C5a antibody patents protect InflaRx N.V. (IFRX) from competitors, supporting the consensus growth estimate for net profit, where the indicator reached -38.50. The financial position depends on capital reserves prior to drug certification. Constant R&D expenditures and negative operating cash flow are gradually depleting the company's existing cash reserves.
Analytical breakdowns for InflaRx (IFRX)
- stock quotes and analyst forecast:
- market capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
- earnings and valuation multiples information:
IFRX - Final Profit|Future Profit InflaRx N.V.|IFRX - Price to Earnings Multiple|Projected Price to Earnings InflaRx NV|IFRX - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization InflaRx|IFRX - Operating profit before amortization|Net earnings per share for the last 12 months InflaRx|IFRX - Net earnings per share for the last four quarters|Year-over-year net earnings per share growth for the last 12 months inflarx.de|IFRX - Earnings per share growth in current year|Expected earnings per share growth for next year InflaRx N.V.
Summary company analytics:IFRX, InflaRx N.V.
Investors are searching InflaRx N.V. (IFRX) financial reports for leading indicators to assess the future value of the business. This metric measures expected earnings per share (EPS) dynamics, neutralizing the time lag of traditional reports by aggregating market forecasts. By analyzing the consensus forecast for forward-looking EPS growth rates, one can evaluate the commercialization potential of new anti-inflammatory drugs relative to current revenues from viral complication therapies.
Key competitors
Expected earnings per share growth for next year ARGX|Earnings growth forecast for next year BioNTech Pharma|Net earnings per share growth forecast for next year Abivax (ABVX)|admabiologics.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PTGX (Protagonist)|Immunovant Inc (IMVT) - Expected net earnings per share growth next year|Kiniksa Pharmaceuticals Ltd - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Grifols Biemat GRFS|Adaptive Biotechnologies (ADPT) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year CLDX|AUPH (Aurinia Pharmaceuticals Inc.) - Earnings growth forecast for next year|BioCryst Pharmaceuticals, Inc. - Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year Vera Pharma (VERA)|Net earnings per share growth forecast for next year DNTH (Dianthus Corp)|Earnings growth forecast for next year PHVS (Pharvaris N.V.)|Earnings growth forecast for next year abcellera.com ABCL|TRML - Net earnings per share growth forecast for next year|Expected earnings per share trend next year PGEN (Precigen Inc)|PHAR (Pharming) - Expected earnings per share growth for next year|Projected earnings per share growth rate for next year NKTR|Expected earnings per share growth for next year UPB|ZBIO: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Immunome (IMNM)|Gossamer Bio Inc - Projected earnings per share growth rate for next year|KalVista Pharmaceuticals Inc - Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year Septerna Pharma (SEPN)|PVLA: Expected earnings per share growth for next year|SVRA: Net earnings per share growth forecast for next year|RIGL (Rigel Pharmaceuticals, Inc.) - Expected earnings per share growth for next year|ANAB - Consensus forecast of earnings per share growth for next year|ATXS (Astria Pharma) - Earnings growth forecast for next year|enGene Corp (ENGN) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year RAPT|JBIO: Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year Aclaris Therapeutics, Inc. ACRS|Expected earnings per share trend next year KYTX|TLSA: Expected earnings per share growth for next year|CABA (Cabaletta Bio Inc) - Projected earnings per share growth rate for next year|Ventyx Biosciences (VTYX) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year THTX (theratech.com)|AVTX (Avalo Therapeutics) - Earnings growth forecast for next year|ELDN: Expected earnings per share trend next year|Earnings growth forecast for next year AGEN|Earnings growth forecast for next year Climb Bio, Inc (CLYM)|Net earnings per share growth forecast for next year Zura Bio Limited ZURA|Expected earnings per share trend next year ATYR|ADAG - Net earnings per share growth forecast for next year|ImageneBio Inc (IMA) - Expected earnings per share growth for next year|STTK: Earnings growth forecast for next year|Equillium (EQ) - Earnings growth forecast for next year|Expected earnings per share growth for next year CNTB|IMUX: Expected earnings per share trend next year|Earnings growth forecast for next year ATRA|Consensus forecast of earnings per share growth for next year X4 Pharmaceuticals Inc.|Net earnings per share growth forecast for next year Adicet Bio, Inc. ACET|CELU - Expected earnings per share growth for next year|INMB - Net earnings per share growth forecast for next year|barinthusbio.com (BRNS) - Expected earnings per share growth for next year|KZR (Kezar Life Sciences, Inc.) - Expected earnings per share growth for next year|SAB Biotherapeutics Inc. (SABS) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Akari Therapeutics plc|Projected earnings per share growth rate for next year ENLV (Enlivex Therapeutics, Ltd.)|Earnings growth forecast for next year QTTB|GOVX - Expected net earnings per share growth next year|Earnings growth forecast for next year EDSA (Edesa Biotech)|Consensus forecast of earnings per share growth for next year iBio Inc (IBIO)|CARM - Net earnings per share growth forecast for next year|XTLB (XTL Bio) - Projected earnings per share growth rate for next year|BOLT: Earnings growth forecast for next year|Net earnings per share change forecast for next year HCWB (HCW Biologics)|Net earnings per share growth forecast for next year Aptevo Therapeutics, Inc.|Net earnings per share growth forecast for next year AIM|Earnings growth forecast for next year ADTX|Earnings growth forecast for next year GRI Bio Corporation (GRI)|Net earnings per share growth forecast for next year XORTX Therapeutics Inc. XRTX|Expected earnings per share trend next year HIND|REVB: Expected earnings per share growth for next year|INDP (Indaptus Therapeutics Inc) - Projected earnings per share growth rate for next year|SCNI (Scinai) - Expected earnings per share growth for next year|CalciMedica - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Affimed NV|Projected earnings per share growth rate for next year ALLK (Allakos Therapeutics)|Expected earnings per share growth for next year HOOK (HOOKIPA Pharma Inc.)|Consensus forecast of earnings per share growth for next year igmbio.com|iTeos - Expected earnings per share growth for next year|Ocean Biomedical Corp - Net earnings per share growth forecast for next year|TCBP: Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year thirdharmonicbio.com THRD
